News
= LISA News
18.09.2024
OeAW and Boehringer Ingelheim Foundation establish new Institute for biomedical artificial intelligence in Vienna
18.09.2024
Valneva Submits Label Extension Applications for its Chikungunya Vaccine, IXCHIQ®, to EMA and Health Canada
18.09.2024
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
17.09.2024
Universität Wien: An Unexpected Result: The Mammalian Inner Ear is a Striking Example of Convergent evolution
17.09.2024
Nationales Referenzzentrum für postvirale Syndrome wird an der MedUni Wien eingerichtet
17.09.2024
CEBINA and Charles River Laboratories announce strategic collaboration to accelerate cutting edge neuroscience research into innovative therapeutics in the DanubeNeuro program
13.09.2024
Valneva Announces the Success of its Private Placement Raising approximately €60 Million
12.09.2024
FFG FORUM 2024: „20 Jahre Zukunft: Perspektiven für den Innovationsstandort Österreich“
11.09.2024
MedUni Vienna: Prostate cancer - New AI model can prevent unnecessary prostate removals
10.09.2024
Austrian LEAD Study: LBG präsentiert neueste Ergebnisse von Österreichs größter Gesundheitsstudie